Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Phagocytic Uptake of Surface modified PLGA Microspheres Using Dendritic Cell

  • Kim, Ji-Seon (College of Pharmacy, Chungbuk National University) ;
  • Lee, Young-Sung (College of Pharmacy, Chungbuk National University) ;
  • Lee, Jung-Gil (College of Pharmacy, Chungbuk National University) ;
  • Park, Jeong-Sook (College of Pharmacy, Chungbuk National University) ;
  • Lee, Jong-Kil (College of Pharmacy, Chungbuk National University) ;
  • Chung, Youn-Bok (College of Pharmacy, Chungbuk National University) ;
  • Han, Kun (College of Pharmacy, Chungbuk National University)
  • Received : 2011.05.11
  • Accepted : 2011.06.11
  • Published : 2011.06.20
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to evaluate the phagocytic uptake of surface modified PLGA microspheres containing ovalbumin (OVA) into dendritic cell. In order to find the most suitable formulation for targeted delivery to antigen presenting cells (APC), OVA was encapsulated by a double emulsion solvent evaporation method with three PLGA microspheres (PLGA 50:50, PLGA 75:25 and PLGA 85:15) and two surface modified microspheres by chitosan and sodium dodecyl sulfate (SDS). Physicochemical properties were evaluated in terms of size, zeta potential, encapsulation efficiency, different scanning calorimeter (DSC), x-ray diffraction, morphology, and OVA release test from microspheres. Phagocytic activity was estimated using dendritic cells and analyzed by fluorescence activated cell sorter (FACS). The result showed that zeta potential of PLGA particles was changed to positive by the chitosan modification. The release profile of chitosan modified PLGA microspheres exhibited sustained release after initial burst. The chitosan modified microspheres had higher phagocytic uptake than the other microspheres. Such physicochemical properties and phagocytic uptake studies lead us to conclude that chitosan modified microspheres is more suitable formulation for the targeted delivery of antigens to APC compared with the other microspheres.

Keywords

References

  1. Barrow, E.L.W., Winchester, G.A., Staas, J.K., Quenelle, D.C., Barrow, W.W., 1998. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages. Antimicrob. Agents Chemother., 42, 2682-2689.
  2. Ben Nasser, I., Boyaka, P.N., Fennira Ben Aissa, F., Jeddi, M., Tome, D. 2003. The [173-196] fragment of ovalbumin suppresses ovalbumin-specific rat IgE responses. Int. Immunopharmacol., 3(12), 1569-1579. https://doi.org/10.1016/S1567-5769(03)00164-4
  3. Janes, K.A., Calvo, P., Alonso, M.J., 2001. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug. Deliv. Rev., 47, 83-97. https://doi.org/10.1016/S0169-409X(00)00123-X
  4. Kim, B.S., Kim, C.S., Kee, K.M., 2008. The intracellular uptake ability of chitosan-coated poly(D,L-lactide-co-glycolide) nanoparticles. Arch. Pharm. Res., 31(8), 1050-1054. https://doi.org/10.1007/s12272-001-1267-5
  5. Langer, R., Folkman, J., 1976. Polymers for sustained release of proteins and other macromolecules. Nature, 263, 797-800. https://doi.org/10.1038/263797a0
  6. Newman, K.D., Samuel, J., Kwon, G., 1998. Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J Control. Release., 54(1), 49-59. https://doi.org/10.1016/S0168-3659(97)00142-9
  7. Okada, H., 1997. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv. Drug Deliv. Rev. 28, 43-70. https://doi.org/10.1016/S0169-409X(97)00050-1
  8. Tabata, Y., Ikada, Y., 1988, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage, Biomaterials.1988 Jul; 9(4), 356-362. https://doi.org/10.1016/0142-9612(88)90033-6
  9. Tobio, M., Gref, R., Sanchez, A., Langer, R., Alonso, M.J., 1998. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration, Pharm. Res. 15(2), 270-275 https://doi.org/10.1023/A:1011922819926
  10. Wang, Y.M., Sato, H., Horikoshi, I., 1997. In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. J. Control. Release, 49, 157-166. https://doi.org/10.1016/S0168-3659(97)00082-5
  11. Yamaguchi, K., Anderson, J.M., 1993. In vivo biocompatibility studies of Medisorb 65/35 D,L-lactide glycolide copolymer microspheres. J. Control. Release, 24, 81-93. https://doi.org/10.1016/0168-3659(93)90169-6